Skip to Main Content

Paper Details

First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive Function.
Cancers (Basel)
1
2023
Author NameAffiliation
Jeffrey M BurnsUniversity of Kansas Alzheimer's Disease Research Center
  • 1 - 1

Datasets

Release 1.2